On April 10, 2025 Evaxion Biotech A/S (NASDAQ: EVAX) ("Evaxion"), a clinical-stage TechBio company specializing in developing AI-Immunology powered vaccines, reported that it will give two presentations and man a booth at the World Vaccine Congress taking place April 21-24, 2025, in Washington, D.C (Press release, Evaxion Biotech, APR 10, 2025, View Source [SID1234651868]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Birgitte Rønø, Chief Scientific Officer at Evaxion, will talk about the application of Evaxion’s AI-Immunology platform for antigen target discovery for cancer vaccines. Pär Comstedt, Vice President, Infectious Disease Vaccine Development at Evaxion, will present the use of AI-Immunology for target discovery for infectious disease vaccines. See details on the presentations below.
The World Vaccine Congress is just one of several scientific, partnering and investor conferences where Evaxion will profile itself and discuss with potential partners and collaborators in the second quarter of 2025.
Throughout the conference, Evaxion invites interested parties to its booth #351 for discussions on effective and accurate target discovery with AI-Immunology as well as our pipeline of vaccine candidates for cancers and infectious diseases.
Presentation details:
Title: AI-powered antigen target discovery for cancer vaccines
Category: Cancer immunotherapy
Location: Room 206
Date/Time: April 23, 2025, at 11.40 ET/17.40 CET
Presenter: Birgitte Rønø, Chief Scientific Officer at Evaxion
Title: AI-powered target discovery for infectious disease vaccines
Category: Emerging and re-emerging diseases
Location: Room 202b
Date/Time: April 23, 2025, at 15.10 ET/21.10 CET
Presenter: Pär Comstedt, VP, Infectious Disease Vaccine Development at Evaxion